Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation Mitigators

In Vivo. 2017 Jan 2;31(1):39-43. doi: 10.21873/invivo.11022.

Abstract

Background/aim: Mitochondrial-targeted gramicidin S (GS)-nitroxide, JP4-039, has been demonstrated to be a potent radiation mitigator, and safe over a wide dose range. In addition, JP4-039 has organ-specific effectiveness when locally applied.

Materials and methods: We tested the effect of another GS-nitroxide, XJB-5-131, which has more effective mitochondrial localization, and compared these results to those for radiation mitigation against the hematopoietic syndrome, and two analogs of JP4-039, which have the same mitochondrial localization signal, but different chemical payloads: JRS527.084 contains a second nitroxide per molecule, and TK649.030 contains an ester group attached to the nitroxide.

Results: The results demonstrate the superiority of JP4-039 as a systemic radiation mitigator.

Conclusion: Structure-activity relationships and bioassays demonstrate that JP4-039 is an optimized small-molecule radiation mitigator.

Keywords: GS-nitroxide; Oxidative stress; radiation mitigation.

MeSH terms

  • Animals
  • Dose-Response Relationship, Radiation
  • Female
  • Mice
  • Mice, Inbred C57BL
  • Molecular Structure
  • Nitrogen Oxides / pharmacology*
  • Radiation Injuries, Experimental / etiology
  • Radiation Injuries, Experimental / prevention & control*
  • Radiation-Protective Agents / administration & dosage
  • Radiation-Protective Agents / pharmacology*
  • Structure-Activity Relationship
  • Whole-Body Irradiation / adverse effects*

Substances

  • JP4-039
  • Nitrogen Oxides
  • Radiation-Protective Agents